Medtronic Claims Share Gains In Cardiovascular And Neurostim
Executive Summary
The company’s revenue was down just 1% year-over-year in the third quarter of fiscal 2021, despite the ongoing impact of the pandemic.
You may also be interested in...
Market Intel: Rivalry Among Insulin Pump Makers Heats Up With Expected Launches In 2021
The global insulin pump market is expected to see double-digit growth, reaching $5.1bn in 2024, with product launches expected by Medtronic, Insulet, Tandem and smaller players in 2021.
Boston Scientific Is Counting On COVID-19 Vaccine To Rebound In 2021
The company expects revenues across its businesses to rapidly return to their pre-pandemic growth rates in the second half of 2021.
Medtronic Brings Radial Access Technology To Brain Interventions
The company has begun a limited release of the radial artery access devices it added to its neurovascular therapies business when it quietly acquired RIST Neurovascular in 2020.